Distinct Genomic Aberrations between Low-Grade and High-Grade Gliomas of Chinese Patients

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Li, Yunbo ^a,d   Wang, Dapeng ^b,f   Wang, Lei ^b   Yu, Jinhai ^a   Du, Danhua ^a   Chen, Ye ^c   Gao, Peng ^a   Wang, Duen Mei ^b   Yu, Jun ^b   Zhang, Feng ^b,e   Fu, Shuanglin ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^c Basic Medical College   (China)

^d JILIN UNIVERSITY   (China)

^e NORTHEAST NORMAL UNIVERSITY   (China)

^f Technology Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADOLESCENT; ADULT; AMINOADIPATE SEMIALDEHYDE SYNTHASE GENE; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER GRADING; CHILD; CHINESE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA BINDING; DNA DETERMINATION; DNA SEQUENCE; EGFR GENE; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOSS; GENETIC GAIN; GENETIC VARIABILITY; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; HYALURONOGLUCOSAMINIDASE 4 GENE; LIGAND BINDING; MALE; NADH DEHYDROGENASE (UBIQUINONE) 1 ALPHA SUBCOMPLEX 5 GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE C KIT; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SPERM ADHESION MOLECULE 1 GENE; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION; VOMERONASAL 1 RECEPTOR 2 GENE; VOMERONASAL 1 RECEPTOR 4 GENE; ZINC FINGER PROTEIN 677 GENE;

ADOLESCENT; ADULT; BASE SEQUENCE; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHILD; CHINA; DNA COPY NUMBER VARIATIONS; DNA PRIMERS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84874302090     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057168     Document Type: Article

References (54)

1. Gladson CL, Prayson RA, Liu WM, (2010) The pathobiology of glioma tumors. Annu Rev Pathol 5: 33-50.
2. Larjavaara S, Mantyla R, Salminen T, Haapasalo H, Raitanen J, et al. (2007) Incidence of gliomas by anatomic location. Neuro Oncol 9: 319-325.
3. Radhakrishnan K, Mokri B, Parisi JE, O'Fallon WM, Sunku J, et al. (1995) The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 37: 67-73.
4. Cheng JX, Liu BL, Zhang X, Lin W, Zhang YQ, et al. (2010) Health-related quality of life in glioma patients in China. BMC Cancer 10: 305.
5. Taylor LP, (2010) Diagnosis, treatment, and prognosis of glioma: five new things. Neurology 75: S28-32.
6. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
7. Blauw HM, Veldink JH, van Es MA, van Vught PW, Saris CG, et al. (2008) Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen. Lancet Neurol 7: 319-326.
8. Stark M, Hayward N, (2007) Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res 67: 2632-2642.
9. Yin D, Ogawa S, Kawamata N, Tunici P, Finocchiaro G, et al. (2009) High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray. Mol Cancer Res 7: 665-677.
10. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, et al. (2003) Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 163: 1033-1043.
11. The Cancer Genome Atlas Research Network, (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
12. Kotliarov Y, Kotliarova S, Charong N, Li A, Walling J, et al. (2009) Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. Cancer Res 69: 1596-1603.
13. Hu J, Jiang C, Ng HK, Pang JC, Tong CY, et al. (2003) Genome-wide allelotype study of primary glioblastoma multiforme. Chin Med J (Engl) 116: 577-583.
14. Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, et al. (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28: 3061-3068.
15. de Tayrac M, Etcheverry A, Aubry M, Saikali S, Hamlat A, et al. (2009) Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression. Genes Chromosomes Cancer 48: 55-68.
16. Ferrer-Luna R, Mata M, Nunez L, Calvar J, Dasi F, et al. (2009) Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression. J Neurooncol 95: 343-354.
17. Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, et al. (2009) Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol 27: 1627-1636.
18. Freire P, Vilela M, Deus H, Kim YW, Koul D, et al. (2008) Exploratory analysis of the copy number alterations in glioblastoma multiforme. PLoS One 3: e4076.
19. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, et al. (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64: 6892-6899.
20. Ohgaki H, Kleihues P, (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170: 1445-1453.
21. Liu F, Park PJ, Lai W, Maher E, Chakravarti A, et al. (2006) A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. Cancer Res 66: 10815-10823.
22. Ruano Y, Mollejo M, Ribalta T, Fiano C, Camacho FI, et al. (2006) Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer 5: 39.
23. Dreyfuss JM, Johnson MD, Park PJ, (2009) Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers. Mol Cancer 8: 71.
24. Jiang R, Mircean C, Shmulevich I, Cogdell D, Jia Y, et al. (2006) Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays. Proteomics 6: 2964-2971.
25. Chakravarti A, Zhai G, Suzuki Y, Sarkesh S, Black PM, et al. (2004) The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol 22: 1926-1933.
26. Jeuken J, van den Broecke C, Gijsen S, Boots-Sprenger S, Wesseling P, (2007) RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations. Acta Neuropathol 114: 121-133.
27. Zohrabian VM, Forzani B, Chau Z, Murali R, Jhanwar-Uniyal M, (2009) Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation. Anticancer Res 29: 119-123.
28. Rao SK, Edwards J, Joshi AD, Siu IM, Riggins GJ, (2010) A survey of glioblastoma genomic amplifications and deletions. J Neurooncol 96: 169-179.
29. Misra A, Pellarin M, Nigro J, Smirnov I, Moore D, et al. (2005) Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma. Clin Cancer Res 11: 2907-2918.
30. Czernicki T, Zegarska J, Paczek L, Cukrowska B, Grajkowska W, et al. (2007) Gene expression profile as a prognostic factor in high-grade gliomas. Int J Oncol 30: 55-64.
31. Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, et al. (2009) Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 4: e7752.
32. Hirose Y, Aldape KD, Chang S, Lamborn K, Berger MS, et al. (2003) Grade II astrocytomas are subgrouped by chromosome aberrations. Cancer Genet Cytogenet 142: 1-7.
33. Marko NF, Prayson RA, Barnett GH, Weil RJ, (2010) Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study. Genomics 95: 16-24.
34. Qaddoumi I, Sultan I, Broniscer A, (2009) Pediatric low-grade gliomas and the need for new options for therapy: Why and how? Cancer Biol Ther 8: 4-10.
35. Liang BC, Hays L, (1996) Mitochondrial DNA copy number changes in human gliomas. Cancer Lett 105: 167-173.
36. Arslantas A, Artan S, Oner U, Muslumanoglu MH, Ozdemir M, et al. (2007) Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas. Pathol Oncol Res 13: 39-46.
37. Idbaih A, Carvalho Silva R, Criniere E, Marie Y, Carpentier C, et al. (2008) Genomic changes in progression of low-grade gliomas. J Neurooncol 90: 133-140.
38. Koschny R, Koschny T, Froster UG, Krupp W, Zuber MA, (2002) Comparative genomic hybridization in glioma: a meta-analysis of 509 cases. Cancer Genet Cytogenet 135: 147-159.
39. Kotliarov Y, Steed ME, Christopher N, Walling J, Su Q, et al. (2006) High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res 66: 9428-9436.
40. Batchelor TT, Betensky RA, Esposito JM, Pham LD, Dorfman MV, et al. (2004) Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res 10: 228-233.
41. Campbell BA, Horsman DE, Maguire J, Young S, Curman D, et al. (2008) Chromosomal alterations in oligodendroglial tumours over multiple surgeries: is tumour progression associated with change in 1p/19q status? J Neurooncol 89: 37-45.
42. Wong KK, Tsang YT, Chang YM, Su J, Di Francesco AM, et al. (2006) Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array. Cancer Res 66: 11172-11178.
43. Kuga D, Mizoguchi M, Guan Y, Hata N, Yoshimoto K, et al. (2008) Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues. Neuro Oncol 10: 995-1003.
44. Vranova V, Necesalova E, Kuglik P, Cejpek P, Pesakova M, et al. (2007) Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization. Oncol Rep 17: 457-464.
45. Peiffer DA, Le JM, Steemers FJ, Chang W, Jenniges T, et al. (2006) High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 16: 1136-1148.
46. Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A, (2012) GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res 40: W478-483.
47. Zhang B, Kirov S, Snoddy J, (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: W741-748.
48. Amberger J, Bocchini CA, Scott AF, Hamosh A, (2009) McKusick's Online Mendelian Inheritance in Man (OMIM). Nucleic Acids Res 37: D793-796.
49. Knudson AG Jr, (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68: 820-823.
50. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, et al. (2005) High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Cancer Res 65: 4088-4096.
51. Stupp R, Tonn JC, Brada M, Pentheroudakis G, (2010) High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21Suppl 5: v190-193.
52. Cavaliere R, Lopes MB, Schiff D, (2005) Low-grade gliomas: an update on pathology and therapy. Lancet Neurol 4: 760-770.
53. Pouratian N, Schiff D, (2010) Management of low-grade glioma. Curr Neurol Neurosci Rep 10: 224-231.
54. Costantini M, Clay O, Auletta F, Bernardi G, (2006) An isochore map of human chromosomes. Genome Res 16: 536-541.